z-logo
open-access-imgOpen Access
Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts
Author(s) -
Paul G. Werthmann,
Lothar Kindermann,
Gunver S. Kienle
Publication year - 2019
Publication title -
complementary medicine research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 38
eISSN - 2504-2106
pISSN - 2504-2092
DOI - 10.1159/000496866
Subject(s) - medicine , viscum album , chemoimmunotherapy , renal cell carcinoma , nephrectomy , isotretinoin , immunotherapy , gastroenterology , surgery , gynecology , kidney , cancer , dermatology , traditional medicine , acne
Metastatic renal cell carcinoma has a poor prognosis. Treatment approaches with immunotherapy show promising results in subpopulations. Viscum album extracts – used as an adjunct to cancer treatment – have cytotoxic, apoptogenic, and immune-stimulating properties and show synergistic effects with chemotherapy agents. Case Report: A 51-year-old man was diagnosed with metastatic renal cell carcinoma of clear cell histology which was classified as pT3a, N1, M1, G3. Nephrectomy was performed, and the patient received chemoimmunotherapy (interferon-α2a, interleukin-2, fluorouracil, isotretinoin). Additionally, he received V. album extracts as intravenous infusions and subcutaneous injections. One year after surgery, the patient was in complete remission, which is ongoing 18 years after the initial diagnosis. Discussion: This case shows an extraordinarily long survival of a metastasized renal cell carcinoma patient under chemoimmunotherapy and fever-inducing V. album extracts. This combined treatment might have synergistically contributed to tumor remission and control. With regard to clinical relevance, further investigations are needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here